Baseline characteristics from the EXCITING-ILD registry
The EXCITING-ILD registry describes the frequency of ILD subtypes, ILD-related impairments, selected comorbidities and diagnostic and treatment patterns in a representative German population.
Authors
- Rainer Karpavicius
- Katharina Buschulte (ORCID: https://orcid.org/0000-0002-7598-5276)
- Christoph Lederer
- M Polke
- Lars Hagmeyer (ORCID: https://orcid.org/0000-0003-4285-1244)
- M. Kreuter
- Marc Höffgen
- Stefan Veitshans
- Vivien Somogyi
- D. Skowasch
- Conrad Wiederhold
- Albert Esselmann
- Marcus Joest
- Philipp Markart (ORCID: https://orcid.org/0000-0002-2050-1924)
- Larissa Schwarzkopf (ORCID: https://orcid.org/0000-0002-9402-7700)
- Andreas Hellmann (ORCID: https://orcid.org/0000-0002-3573-5344)
- Phillen Maqhuzu (ORCID: https://orcid.org/0000-0002-3301-3874)
- Peter Hammerl
- Philipp Höger (ORCID: https://orcid.org/0009-0006-6637-9166)
- Andreas Guenther
- Michael Pfeifer
- Juergen Behr
- Christoph Stolpe
- Hans-Joachim Kabitz
Institutions
- Zimmer Biomet (Netherlands) (NL)
- Johannes Gutenberg University Mainz (DE)
- Heidelberg University (DE)
- University Hospital Bonn (DE)
- Helmholtz Zentrum München (DE)
- LMU Klinikum (DE)
- Institut für Urheber- und Medienrecht (DE)
- Krankenhaus Bethanien (DE)
- German Center for Lung Research (DE)
- Universities of Giessen and Marburg Lung Center (DE)
- Klinik Donaustauf (DE)
- Klinikum Rheine (DE)
- Klinikum Fulda (DE)
- Kantonsspital Aarau (CH)
- IFT Institut für Therapieforschung (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjresp-2024-002902
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- CSL Behring
- Deutsches Zentrum für Lungenforschung